Paul Workman has been elected as a Fellow of AACR Academy – ICR
The Institute of Cancer Research (ICR) posted on LinkedIn:
“NEW: We are delighted to announce that Professor Paul Workman has been elected as a Fellow of the American Association for Cancer Research (AACR) Academy.
This honour is only granted to those whose work has made a profound and lasting impact on cancer research.
Professor Workman is one of 33 new Fellows elected into the AACR Academy in 2025.
Professor Paul Workman, Group Leader in the ICR Centre for Cancer Drug Discovery and Harrap Professor of Pharmacology and Therapeutics at The Institute of Cancer Research, London, said:
‘I’m very excited to be elected to the AACR Academy and humbled to join this illustrious group of cancer researchers. Drug discovery and development is a team sport and I’m hugely grateful to all my very many trainees, technical staff, colleagues and collaborators – and also the funders, donors and institutions that have supported me throughout my career – especially, over the last 28 years, the ICR.”
Read more here.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023